Drug discovery banner

Drug Discovery Drug Discovery


Drug Discovery Overview

Structure-based drug design, synthesis and analytical support to discover promising new therapeutics

The Drug Discovery Platform provides structure-based drug design and synthetic support to researchers. With our drug discovery expertise and state-of-the-art analytical instrument facilities, we identify and validate promising new biological and chemical entities (including biomarkers) for life-threatening diseases. The new therapeutic entities then undergo a series of optimization processes to deliver drug candidates (CDs) which may ultimately lead to clinical trials in the Centre for Innovative Medicine (CIM). The Drug Discovery Platform also provides access and training to users from both academia and industry on a broad range of cutting-edge technologies.

Platform News and Events

News and Events

Asset Publisher

Recent Technological Advances in Microbiome and Tissue Analysis (September 12, 2017)

The main focus for this conference will be on the analyses of microorganisms and human tissue samples with modern...

The 3rd International Drug Discovery and Development Forum (June 12-16, 2017)

Theme: Challenges to drug discovery and development in the genomics era

Drug Discovery Leader

Dr. Bertrand Jean-Claude


Sanjoy Kumar Das, PhD

Andrée Gravel, PhD
Carine Bourguet, PhD
Nidia Lauzon, PhD

514-934-1934 ext. 76350
Office: E 01.3625.1